World's Best Scientists 2026 revealed!
Thomas M. Grogan

Thomas M. Grogan

D-Index & Metrics

Medicine

D-Index
87
Citations
38634
World Ranking
13435
National Ranking
189

Overview

Thomas M. Grogan is affiliated with Roche (Switzerland) in Switzerland. Their research spans multiple intersecting fields, primarily focused on Physics and Astronomy with notable contributions in the subfields of Atomic and Molecular Physics, and Optics, as well as Immunology and Allergy.

The scientist's work covers a range of topics including:

  • Allergic Rhinitis and Sensitization
  • Cold Atom Physics and Bose-Einstein Condensates
  • Quantum optics and atomic interactions
  • Atomic and Subatomic Physics Research

Grogan has coauthored papers with several researchers, demonstrating diverse collaborative engagement. Frequent co-authors include:

  • Marcos A. Sanchez-Gonzalez
  • Aravind Reddy
  • A. Bonansea
  • Christine Wright
  • Frank Lichtenberger

Their publication record includes articles in journals such as:

  • Annals of Allergy Asthma & Immunology
  • Physical review. A/Physical review, A

Recent papers authored or co-authored by Grogan highlight research in both medical and physical sciences:

  • ALLERGIC RHINITIS AND MENTAL HEALTH: ALLERGY MEDICATIONS ARE NOT ENOUGH (2024), published in Annals of Allergy Asthma & Immunology
  • Blackbody radiation Zeeman shift in Rydberg atoms (2025), published in Physical review. A/Physical review, A

This combination of topics demonstrates a multidisciplinary approach, where Grogan bridges complex areas of quantum physics with applied immunological studies.

The focus on atomic interactions and cold atom physics aligns with their involvement in quantum optics research and understanding atomic and subatomic particle behavior, while the work on allergic rhinitis indicates broader implications for health sciences.

Best Publications

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

    Richard I. Fisher;Ellen R. Gaynor;Steve Dahlberg;Martin M. Oken

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

    Thomas P. Miller;Steve Dahlberg;J. Robert Cassady;David J. Adelstein

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    Nathalie A. Johnson;Graham W. Slack;Kerry J. Savage;Joseph M. Connors

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

    S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks

  • Expression of Vascular Endothelial Growth Factor and Its Receptors in Hematopoietic Malignancies

    William T. Bellamy;Lynne Richter;Yvette Frutiger;Thomas M. Grogan

  • Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

    W. S. Dalton;T. M. Grogan;P. S. Meltzer;R. J. Scheper

  • Automated biological reaction apparatus

    Keith G. Copeland;Thomas M. Grogan;Charles Hassen;William Ross Humphreys

  • Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

    Silvia Bea;Andreas Zettl;George Wright;Itziar Salaverria

  • Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the Message

    Raymund R. Tubbs;J. D. Pettay;P. C. Roche;M. H. Stoler

  • Methods to Detect P-Glycoprotein-associated Multidrug Resistance in Patients' Tumors: Consensus Recommendations

    William T. Beck;Thomas M. Grogan;Cheryl L. Willman;Carlos Cordon-Cardo

  • P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

    Thomas P. Miller;Thomas M. Grogan;William S. Dalton;Catherine M. Spier

  • Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

    William T. Bellamy;Lynne Richter;Davuud Sirjani;Concepcion Roxas

  • Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.

    Elaine M Hurt;Adrian Wiestner;Andreas Rosenwald;A.L Shaffer

  • P-glycoprotein expression and function in circulating blood cells from normal volunteers

    Walter T. Klimecki;Bernard W. Futscher;Thomas M. Grogan;William S. Dalton

  • Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.

    Lisa M. Rimsza;Robin A. Roberts;Thomas P. Miller;Joseph M. Unger

Frequent Co-Authors

Thomas P. Miller
Thomas P. Miller University of Arizona
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Elias Campo
Elias Campo University of Barcelona
Louis M. Staudt
Louis M. Staudt National Institutes of Health
William S. Dalton
William S. Dalton University of South Florida
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Jan Delabie
Jan Delabie University Health Network
Raymond R. Tubbs
Raymond R. Tubbs Cleveland Clinic
Andreas Rosenwald
Andreas Rosenwald University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean attending traditional, on-campus programs. There are numerous flexible online options for those interested in healthcare roles. For example, affordable np programs offer a route to becoming a nurse practitioner without the high tuition fees of many universities.

Interested in starting your nursing journey from scratch or advancing your existing credentials? nursing degree online options provide a convenient pathway, allowing students to balance work and study. Those looking to pursue advanced leadership or academic positions may consider doctorate in nursing education online programs, which open doors to both clinical and research roles.

If you’re already a registered nurse and seeking to enhance your qualifications, cheapest bsn programs can help you complete your BSN degree at a lower cost. These diverse online pathways make it easier to enter or advance in the healthcare field without sacrificing flexibility or affordability.

Best Scientists Citing Thomas M. Grogan

Trending Scientists